Ranked by reported Q1 2026 13F market value
Share of total reported institutional value in TVRD held by the largest 10 / 25 filers.
| # | Institution | Shares Held | Market Value | QoQ Change | Ownership % | % of Fund |
|---|---|---|---|---|---|---|
| 1 | Slate Path Capital LP | 704K | $2.2M | 0.0% | 7.505% | 0.03% |
| 2 | BlackRock, Inc. | 388K | $1.2M | -0.8% | 4.137% | 0.00% |
| 3 | VANGUARD CAPITAL MANAGEMENT LLC | 345K | $1.1M | β | 3.674% | 0.00% |
| 4 | AMERICAN FINANCIAL GROUP INC | 224K | $711K | 0.0% | 2.384% | 0.26% |
| 5 | GEODE CAPITAL MANAGEMENT, LLC | 182K | $580K | +16.0% | 1.944% | 0.00% |
| 6 | SILVERCREST ASSET MANAGEMENT GROUP LLC | 101K | $321K | 0.0% | 1.077% | 0.00% |
| 7 | STATE STREET CORP | 97K | $309K | -15.8% | 1.036% | 0.00% |
| 8 | RENAISSANCE TECHNOLOGIES LLC | 92K | $293K | -11.9% | 0.982% | 0.00% |
| 9 | MORGAN STANLEY | 73K | $232K | -13.7% | 0.777% | 0.00% |
| 10 | Duncan Williams Asset Management, LLC | 63K | $201K | -21.7% | 0.674% | 0.06% |
| 11 | UBS Group AG | 50K | $160K | +41.9% | 0.538% | 0.00% |
| 12 | NORTHERN TRUST CORP | 49K | $156K | +2.5% | 0.523% | 0.00% |
| 13 | VANGUARD FIDUCIARY TRUST CO | 47K | $149K | β | 0.500% | 0.00% |
| 14 | AQR CAPITAL MANAGEMENT LLC | 42K | $134K | β | 0.450% | 0.00% |
| 15 | GREAT LAKES ADVISORS, LLC | 36K | $115K | β | 0.386% | 0.00% |
| 16 | VANGUARD PORTFOLIO MANAGEMENT LLC | 34K | $108K | β | 0.361% | 0.00% |
| 17 | Squarepoint Ops LLC | 33K | $104K | -36.9% | 0.348% | 0.00% |
| 18 | GOLDMAN SACHS GROUP INC | 24K | $76K | -27.9% | 0.255% | 0.00% |
| 19 | Russell Investments Group, Ltd. | 23K | $74K | +46.0% | 0.248% | 0.00% |
| 20 | FARALLON CAPITAL MANAGEMENT LLC | 21K | $68K | -50.4% | 0.229% | 0.00% |
| 21 | Bank of New York Mellon Corp | 17K | $55K | -4.1% | 0.185% | 0.00% |
| 22 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 12K | $37K | -0.1% | 0.126% | 0.00% |
| 23 | SRS Capital Advisors, Inc. | 8K | $26K | -0.8% | 0.089% | 0.00% |
| 24 | FMR LLC | 5K | $17K | -20.0% | 0.056% | 0.00% |
| 25 | Tower Research Capital LLC (TRC) | 3K | $11K | +38.0% | 0.037% | 0.00% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). β% of Fundβ shows how much of that investorβs total 13F portfolio is invested in TVRD β a direct measure of their conviction.
Filings activity in TVRD during Q1 2026, grouped by how each filer changed its position.
Institutions that opened a new TVRD position in Q1 2026
Institutions that fully closed their TVRD position in Q1 2026
4 quarters of 13F filings Β· Ξ columns show change vs prior quarter
| Quarter | Inst. Holders | Ξ Holders | Ownership % | Ξ Ownership | Total 13F Value | Ξ Value |
|---|---|---|---|---|---|---|
| Q1 2026 | 65 | +1.6% | 34.68% | 14.03 pp | $9M | 29% |
| Q4 2025 | 64 | +1.6% | 48.71% | 151.28 pp | $12M | 88% |
| Q3 2025 | 63 | +34% | 199.99% | +21.69 pp | $102M | +130% |
| Q2 2025 | 47 | β | 178.30% | β | $44M | β |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Ξ columns compare to the immediately prior filed quarter.
Quick answers to the most common questions about buying TVRD stock.
Based on Q1 2026 13F filings, institutional ownership of Tvardi Therapeutics, Inc. stands at 34.7%, held across 65 reporting institutions.
Slate Path Capital LP is the largest reported institutional holder of TVRD, with approximately 704,118 shares worth $0.00B as of Q1 2026.
Yes β 1 widely-followed marquee investor appear among the top 25 institutional holders of TVRD, including RENAISSANCE TECHNOLOGIES LLC.
Our composite Smart Money Score for TVRD is 40 out of 100 (Neutral). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.
15 institutions opened new positions in TVRD during Q1 2026, while 14 fully exited. 11 added to existing positions and 38 trimmed.
TVRD institutional ownership fell by 14.03 percentage points quarter-over-quarter, with a net change of +1 holders.
The top 10 institutions account for 84.0% of all reported 13F value in TVRD, and the top 25 account for 99.1%.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.
Tvardi Therapeutics, Inc. (TVRD) Institutional Ownership